Revision history of "Role of plasma metalloproteinases as biomarkers in the prevention of colorectal cancer" (Q3153740)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 March 2024

20 December 2023

12 June 2023

10 June 2023

4 August 2022

  • curprev 08:2608:26, 4 August 2022DG Regio talk contribs 75,169 bytes +51,546 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, fr, de, it, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

16 January 2022

17 December 2021

9 December 2021

4 December 2021

12 October 2021

  • curprev 15:2315:23, 12 October 2021DG Regio talk contribs 12,778 bytes +145 Changed label, description and/or aliases in en: translated_label
  • curprev 15:2315:23, 12 October 2021DG Regio talk contribs 12,633 bytes +2,414 Created claim: summary (P836): The available techniques (collonoscopy and stool occult blood immunological test (Sohi) for colorectal cancer screening (CRC) are clearly insufficient and poorly accepted by the population, and it is therefore considered necessary to identify new non-invasive tests that allow early detection of the development of CRC. Metalloproteinases (MMP) are enzymes that have neoangiogenic properties and can induce cell proliferation. It has recently been o...

10 October 2021

9 October 2021

8 October 2021